Trial NCT03255083

View at ClinicalTrials.gov 
Org. Study IDs: DS1205-A-U101

Last trial update was posted on 2022-01-19

MeSH Interventions

Osimertinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer (NSCLC)

Stopping Reasons

This study was terminated based on a business decision by the Sponsor.

Limitations And Caveats

This study was terminated based on a business decision by the Sponsor.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID